Pregnancy-induced hypertension, pre-eclampsia and eclampsia are parts of the hypertensive syndrome which is a life-threatening condition both for mother and fetus. Apart from being associated with unpredictable onset, it is incurable, except by ending the pregnancy. Its incidence is approximately between 6 - 10% of pregnant women. There is no unique definition and classification of the hypertensive syndrome in pregnancy, i.e. they differ from one expert group to another. RISKS OF PREGNANCY-INDUCED HYPERTENSION: Pregnancy-induced hypertension syndrome can cause placental abruption, intracranial hemorrhage, liver lesions, acute renal disorders and disseminated intravascular coagulation (DIC), adult respiratory distress syndrome (ARDS), hypervolemia and inhalation of gastric content, due to deep sedation. TREATMENT OF PREGNANCY-INDUCED HYPERTENSION: Delivery is always appropriate therapy for the mother, but may not be a good solution for the fetus. Standard treatment of preeclampsia includes: anticonvulsive therapy, antihypertensive therapy, excessive fluid administration, and if necessary, management of oliguria, DIC, pulmonary edema and recovery of liver function. THE OUTCOME OF PREGNANCY-INDUCED HYPERTENSION (PERINATAL AND MATERNAL MORTALITY): Maternal mortality due to pregnancy-induced hypertension is 15 - 33% out of the total number of maternal deaths. Newborn infants of mothers with pregnancy-induced hypertension present with intrauterine growth retardation, prematurity, dysmaturity and necrotizing enterocolitis. Pregnancy-induced hypertension is one of the major causes of maternal and fetal/neonatal morbidity and mortality.

It is most optimal to administer a single-dose of the first generation cephalosporins -cefazolin- immediately following the clamping of the umbilical cord as well as in preoperative prophylaxis in gynaecological operations.

Congenital anomalies of cardiovascular system and respiratory disorders were 6-8 times more frequent in newborns of diabetic mothers than in newborns of healthy mothers.

The primary health care has a significant role in the process of reproduction of the population and these results point to the necessity of a more active role in the improvement of women's health, as well as in the implementation of measures in the population planning policy.

The planned pregnancy in patients treated for breast cancer was earlier inconceivable for oncologists and gynecologists. Our study presented a case of pregnancy after the patient had been operated and irradiated for breast cancer